Kheirkhah Ahmad, Crnej Alja, Ren Ai, Mullins Andrew, Satitpitakul Vannarut, Hamrah Pedram, Schaumberg Debra, Dana Reza
*Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA; †Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; ‡Cornea Service and Boston Image Reading Center, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA; §Shire, Lexington, MA; ¶Department of Epidemiology, Harvard School of Public Health, Boston, MA; and ‖Department of Ophthalmology & Vision Science, University of Utah School of Medicine, Salt Lake City, UT.
Cornea. 2017 Aug;36(8):893-897. doi: 10.1097/ICO.0000000000001216.
Patients' perceptions of the effectiveness of a treatment, or perceived treatment effectiveness (PTE), play an important role in medicine. This study aimed to evaluate patients' PTE in dry eye disease (DED) and investigate factors contributing to these patients' perceptions.
This cross-sectional study included 66 patients with DED. At enrollment, all patients had comprehensive ophthalmic assessment. In addition, to evaluate the patient's PTE, they were asked to use a 10-point scale ranging from "strongly disagree (score 1)" to "strongly agree (score 10)" to score their views on whether their DED treatments had been effective. Changes in clinical parameters of DED over time during their care were also evaluated retrospectively and correlated with the patients' PTE.
The mean age of patients was 55.7 years; 79% were women. Regarding patients' PTE, 36.4% strongly (score 10) and 53.0% moderately (scores 6-9) believed that their DED treatment had been effective. However, 10.6% thought that their treatment had not been effective (scores 1-5). Less favorable PTE for the DED treatment was significantly associated with a younger age (P < 0.001), current use of antidepressant medications (P = 0.01), and a higher Ocular Surface Disease Index score (P = 0.01) at enrollment.
A majority of patients with DED have positive perceptions regarding the effectiveness of their treatments. Less favorable perceptions are associated with more severe ocular symptoms and nonocular parameters such as younger age and current antidepressant use. In DED management, assessing patients' PTE should be considered as an important part of clinical practice.
患者对治疗效果的认知,即感知治疗效果(PTE),在医学中起着重要作用。本研究旨在评估干眼症(DED)患者的PTE,并调查影响这些患者认知的因素。
这项横断面研究纳入了66例DED患者。入组时,所有患者均接受了全面的眼科评估。此外,为评估患者的PTE,要求他们使用从“强烈不同意(1分)”到“强烈同意(10分)”的10分制量表,对其DED治疗是否有效进行评分。还回顾性评估了患者在治疗期间DED临床参数随时间的变化,并将其与患者的PTE进行关联分析。
患者的平均年龄为55.7岁;79%为女性。关于患者的PTE,36.4%的患者强烈(10分)且53.0%的患者中度(6 - 9分)认为他们的DED治疗有效。然而,10.6%的患者认为他们的治疗无效(1 - 5分)。DED治疗的PTE较差与入组时年龄较小(P < 0.001)、当前使用抗抑郁药物(P = 0.01)以及较高的眼表疾病指数评分(P = 0.01)显著相关。
大多数DED患者对其治疗效果有积极的认知。较差的认知与更严重的眼部症状以及年龄较小和当前使用抗抑郁药物等非眼部参数有关。在DED的管理中,评估患者的PTE应被视为临床实践的重要组成部分。